Navigation

Appraisals in development

This table lists NICE technology appraisals. The list can be sorted by title (alphabetically), wave number, anticipated publication date and process. You can also click the appraisal title for full details, or click a column heading to sort the list by that column.

Appraisals in development

Results 41-60 of 152

Title Anticipated publication date Referral date Process
Kidney transplantation (rejection) - belatacept [ID87] TBC Jul 2009 STA
Kidney transplantation (rejection) - everolimus [ID117] TBC Jul 2009
Leukaemia (acute lymphoblastic) - dasatinib [ID386] TBC Jun 2008 STA
Lung cancer (non-small cell) - afatinib [ID357] TBC Jul 2010 STA
Lung cancer (non-small-cell) - cetuximab [ID9] TBC Dec 2007 STA
Lung cancer (non-small-cell, advanced or metastatic maintenance treatment) - erlotinib (in combination with bevacizumab) [ID44] TBC Nov 2008 STA
Lung cancer (non-small-cell, advanced or metastatic second line) - erlotinib (in combination with bevacizumab) [ID43] TBC Nov 2008 STA
Lung cancer (non-small-cell, second line treatment) - vandetanib [ID46] TBC Nov 2008 STA
Lymphoma (follicular non Hodgkin's - advanced) - bortezomib [ID407] TBC Nov 2010 STA
Lymphoma (mantle cell) - bendamustine (1st line, with rituximab) [ID609] TBC May 2012 STA
Lymphoma (non Hodgkin's) - bendamustine (with rituximab) [ID434] TBC Jan 2011 STA
Lymphoma (non Hodgkin's, peripheral T-cell) - pralatrexate [ID368] TBC Sep 2010 STA
Macular oedema (diabetic) - pegaptanib sodium [ID452] TBC Mar 2011 STA
Melanoma (advanced and metastatic) - temozolomide [ID316] TBC Jun 2008 STA
Melanoma (BRAF V600, unresectable, metastatic) - dabrafenib [ID605] TBC STA
Melanoma (BRAF V600E mutation positive, unresectable, metastatic) - dabrafenib and trametinib [ID605] TBC STA
Melanoma (previously untreated unresectable stage III or IV) - ipilimumab [ID74] TBC Nov 2008 STA
Multiple myeloma (newly diagnosed) - lenalidomide [ID474] TBC Jul 2011 STA
Multiple myeloma (one prior therapy) - vorinostat (with bortezomib) [ID501] TBC Nov 2011 STA
Multiple myeloma - bortezomib (consolidation therapy) [ID529] TBC May 2012 STA

This page was last updated: 17 April 2014

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.